Related Experiment Video
Updated: Jun 22, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic metabolic rewiring in
Nicholas Sim1, Jean-Michel Carter1, Kamalakshi Deka1
1School of Biological Sciences (SBS), Nanyang Technological University (NTU), 60 Nanyang Drive, Singapore, 637551, Singapore.
Abstract:
Triple Negative Breast Cancer (TNBC) is the most aggressive breast cancer subtype suffering from limited targeted treatment options. Following recent reports correlating Fibroblast growth factor-inducible 14 (Fn14) receptor overexpression in Estrogen Receptor (ER)-negative breast cancers with metastatic events, we show that Fn14 is specifically overexpressed in TNBC patients and associated with poor survival. We demonstrate that constitutive Fn14 signalling rewires the transcriptomic and epigenomic landscape of TNBC, leading to enhanced tumour growth and metastasis. We further illustrate that such mechanisms activate TNBC-specific super enhancers (SE) to drive the transcriptional activation of cancer dependency genes via chromatin looping. In particular, we uncover the SE-driven upregulation of Nicotinamide phosphoribosyltransferase (NAMPT), which promotes NAD+ and ATP metabolic reprogramming critical for filopodia formation and metastasis. Collectively, our study details the complex mechanistic link between TWEAK/Fn14 signalling and TNBC metastasis, which reveals several vulnerabilities which could be pursued for the targeted treatment of TNBC patients.
Insights
Fibroblast growth factor-inducible 14 (Fn14) receptor is overexpressed in Triple Negative Breast Cancer (TNBC), driving tumor growth and metastasis. Targeting Fn14 signaling may offer new therapeutic strategies for TNBC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Triple Negative Breast Cancer (TNBC) is an aggressive subtype with limited treatment options.
- Fibroblast growth factor-inducible 14 (Fn14) receptor overexpression is linked to metastasis in Estrogen Receptor (ER)-negative breast cancers.
Purpose of the Study:
- To investigate the role of Fn14 in TNBC.
- To elucidate the mechanisms by which Fn14 signaling contributes to TNBC progression and metastasis.
- To identify potential therapeutic targets in TNBC.
Main Methods:
- Analysis of Fn14 expression in TNBC patients.
- Transcriptomic and epigenomic profiling of TNBC cells.
- Investigation of super enhancer (SE) activity and chromatin looping.
- Assessment of Nicotinamide phosphoribosyltransferase (NAMPT) regulation.
Main Results:
- Fn14 is overexpressed in TNBC and associated with poor survival.
- Fn14 signaling alters the transcriptomic and epigenomic landscape, promoting tumor growth and metastasis.
- SEs drive upregulation of NAMPT, critical for NAD+/ATP metabolism and metastasis.
Conclusions:
- TWEAK/Fn14 signaling is mechanistically linked to TNBC metastasis.
- Targeting Fn14 and its downstream pathways presents potential therapeutic vulnerabilities for TNBC.
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Methods of Nuclear Reprogramming

